Literature DB >> 6206986

Laser therapy in patients with primary lung cancer.

A Arabian, S V Spagnolo.   

Abstract

Twenty-eight therapeutic bronchoscopic procedures with laser were carried out on 20 patients with primary lung cancer. Indications for laser bronchoscopic study were nonresectable, endoscopically visible tumor in patients who had any of the following complications after chemotherapy and/or radiation therapy: increasing dyspnea, postobstructive pneumonia, atelectasis, or hemoptysis from an endoscopically visible site. Symptomatic benefit was noted by 15 of 20 patients after laser therapy. There were two procedure-related deaths. Our conclusions regarding selection of patients for laser therapy of endotracheal and endobronchial lesions are given.

Entities:  

Mesh:

Year:  1984        PMID: 6206986     DOI: 10.1378/chest.86.4.519

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Bronchoscopic cryotherapy for advanced bronchial carcinoma.

Authors:  D A Walsh; M O Maiwand; A R Nath; P Lockwood; M H Lloyd; M Saab
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

2.  Dyspnea and cancer: support in agonizing conditions.

Authors:  P Drings
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

Review 3.  Complications of endobronchial neodymium-Yag (Nd:Yag) laser application.

Authors:  R G Vanderschueren; C J Westermann
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 4.  Indication and results of endobronchial laser therapy.

Authors:  R Dierkesmann
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 5.  Endoscopic palliation of tracheobronchial malignancies.

Authors:  M R Hetzel; S G Smith
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

Review 6.  Bronchoscopic NdYAG laser treatment in lung cancer, 30 years on: an institutional review.

Authors:  K Moghissi; Kate Dixon
Journal:  Lasers Med Sci       Date:  2006-09-27       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.